Lassa Virus News and Research

RSS
Lassa virus or Lassa viral haemorrhagic fever is an acute illness of 1-4 weeks duration that occurs in West Africa. Though first described in the 1950s, the virus causing the disease was not identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae. Lassa fever is known to be endemic in Guinea (Conakry), Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.

Further Reading

Areas hospitable to Lassa virus spread may extend in the next several decades

Areas hospitable to Lassa virus spread may extend in the next several decades

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

New vaccine shows promise to fight Lassa virus

New vaccine shows promise to fight Lassa virus

Study shows how a critical Lassa virus protein drives infection

Study shows how a critical Lassa virus protein drives infection

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

The biochemical mechanisms of remdesivir-mediated RNA synthesis inhibition

Recognizing viral genomes in quick, ‘CRISP’ ways

Recognizing viral genomes in quick, ‘CRISP’ ways

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

CEPI and IVI announce new research program to expand access to COVID-19 vaccines in Africa

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

UTMB researchers receive $11.3 million grant to study immunopathogenesis of Ebola

Researchers present COVID RdRp structure at 2.5A

Researchers present COVID RdRp structure at 2.5A

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

Viruses can steal genetic signals from hosts to expand their own genomes

Viruses can steal genetic signals from hosts to expand their own genomes

Remdesivir drug stops novel coronavirus from replicating

Remdesivir drug stops novel coronavirus from replicating

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Investigational vaccine protects macaques against four types of hemorrhagic fever viruses

Vaccine for Lassa fever set to enter clinical testing in humans

Vaccine for Lassa fever set to enter clinical testing in humans

Study reveals Lassa virus' soft spot

Study reveals Lassa virus' soft spot

Harvard scientists uncover key mechanism that allows viruses to replicate

Harvard scientists uncover key mechanism that allows viruses to replicate

New disease surveillance tool enables early detection of viral outbreaks

New disease surveillance tool enables early detection of viral outbreaks

A new vaccine shows promise in protecting people from rabies, Lassa fever

A new vaccine shows promise in protecting people from rabies, Lassa fever